跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment
Yi Fen Wang
, Chun Ju Chang
*
, Jen Hwey Chiu
, Chin Ping Lin
, Wing Yin Li
, Shyue Yih Chang
, Pen Yuan Chu
,
Shyh Kuan Tai
, Yu Jen Chen
*
此作品的通信作者
醫學系耳鼻喉學科
研究成果
:
Article
›
同行評審
17
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Cisplatin Treatment
100%
Nm23
100%
Cisplatin
36%
Squamous Carcinoma Cells
27%
Knockdown
18%
Tumor
18%
Overexpression
18%
Patient Prognosis
18%
Clinical Significance
9%
Sigma Phase
9%
Cell Response
9%
Human Head
9%
Putative Drug Targets
9%
Best Response
9%
Surgical Specimen
9%
In Vitro Study
9%
Carcinoma Cell Lines
9%
Cisplatin-induced
9%
Immunohistochemistry
9%
Stable Clones
9%
Treatment Response
9%
Cyclin A
9%
Clinical Observation
9%
Phase Accumulation
9%
Chemosensitivity
9%
Cyclin E1
9%
Cervical Metastasis
9%
Locoregional Recurrence
9%
Response to Chemotherapy
9%
SAS Cell
9%
Adjuvant Chemoradiotherapy
9%
Human Neck
9%
Immunology and Microbiology
Squamous Cell
100%
Neck
100%
Squamous Cell Carcinoma Cell
33%
Cytotoxicity
16%
Downregulation
16%
Cycline
16%
Chemosensitivity
16%
Head and Neck Squamous Cell Carcinoma Cell Line
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Head and Neck Squamous Cell Carcinoma
100%
Neoplasm
25%
Recurrent Disease
12%
Chemotherapy
12%
Cycline
12%
Chemoradiation Therapy
12%
Cytotoxicity
12%